PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CIRI, Centre International de Recherche en Infectiologie (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France; VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, 69008, Lyon, France; International Associated Laboratory RespiVir (LIA VirPath-LVMC France-Québec), Université Laval, QC, G1V 4G2, Québec, Canada.\', \'Signia Therapeutics, 60 Avenue Rockefeller, 69008, Lyon, France.\', \'CIRI, Centre International de Recherche en Infectiologie (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France; VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, 69008, Lyon, France; International Associated Laboratory RespiVir (LIA VirPath-LVMC France-Québec), Université Laval, QC, G1V 4G2, Québec, Canada. Electronic address: manuel.rosa-calatrava@univ-lyon1.fr.\', \'CIRI, Centre International de Recherche en Infectiologie (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France; International Associated Laboratory RespiVir (LIA VirPath-LVMC France-Québec), Université Laval, QC, G1V 4G2, Québec, Canada. Electronic address: mario-andres.pizzorno@univ-lyon1.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1471-4892(21)00162-410.1016/j.coph.2021.11.002
?:hasPublicationType
?:journal
  • Current opinion in pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34915400
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.504
?:rankingScore_hIndex
  • 114
?:title
  • Treatments for COVID-19: Lessons from 2020 and new therapeutic options.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34915400>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34915400>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all